Current concepts on coronary revascularization in diabetic patients

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

(2011) Jeffrey L. Anderson et al.   CIRCULATION

Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome

(2011) José Luis Ferreiro et al.   CIRCULATION

Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease

(2011) Davide Capodanno et al.   Circulation-Cardiovascular Interventions

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

(2011) D. J. Angiolillo et al.   EUROPEAN HEART JOURNAL

5-Year Follow-Up of Coronary Revascularization in Diabetic Patients With Multivessel Coronary Artery Disease

(2011) Yoshinobu Onuma et al.   JACC-Cardiovascular Interventions

The SPIRIT V Study

(2011) Eberhard Grube et al.   JACC-Cardiovascular Interventions

Radial Artery Grafts vs Saphenous Vein Grafts in Coronary Artery Bypass Surgery

(2011) Steven Goldman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Stent Thrombosis and Bleeding Complications After Implantation of Sirolimus-Eluting Coronary Stents in an Unselected Worldwide Population

(2011) Philip Urban et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bilateral mammary artery vs. single mammary artery grafting: promising early results: but will the match finish with enough players?

(2010) A. P. Kappetein   EUROPEAN HEART JOURNAL

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

(2010) Stefan James et al.   EUROPEAN HEART JOURNAL

Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART)

(2010) D. P. Taggart et al.   EUROPEAN HEART JOURNAL

Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

(2010) et al.   EUROPEAN HEART JOURNAL

Randomized Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Diabetic Patients

(2010) Akhil Kapur et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease

(2010) Adrian P. Banning et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

(2010) Shamir R Mehta et al.   LANCET

Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Global estimates of the prevalence of diabetes for 2010 and 2030

(2009) J.E. Shaw et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials

(2009) G. De Luca et al.   EUROPEAN HEART JOURNAL

Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart

(2009) Matteo Anselmino et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

5-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation

(2009) Adriano Caixeta et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials

(2009) Mark A Hlatky et al.   LANCET

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

(2008) Stephen D. Wiviott et al.   CIRCULATION

Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes Mellitus

(2008) Pallav Garg et al.   CIRCULATION

Routine Use of Bilateral Skeletonized Internal Thoracic Artery Grafting

(2008) D. Pevni et al.   CIRCULATION

Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk

(2008) Tina Ken Schramm et al.   CIRCULATION

Platelet glycoprotein IIb/IIIa receptor inhibitors--end of an era?

(2008) M. Roffi et al.   EUROPEAN HEART JOURNAL

Prasugrel: a novel platelet ADP P2Y12receptor antagonist. A review on its mechanism of action and clinical development

(2008) Dominick J Angiolillo et al.   EXPERT OPINION ON PHARMACOTHERAPY

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial

(2008) Hisao Ogawa   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Drug-Eluting Stent Thrombosis

(2008) José M. de la Torre-Hernández et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and Efficacy of Bivalirudin Monotherapy in Patients With Diabetes Mellitus and Acute Coronary Syndromes

(2008) Frederick Feit et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

(2008) Stephan Windecker et al.   LANCET

Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting in Multivessel Coronary Disease

(2008) Edward L. Hannan et al.   NEW ENGLAND JOURNAL OF MEDICINE